MedTrace Logo

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

NCT03423485 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2018-10-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the CG-100 device, a single use, temporary intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic)

Conditions

  • Colorectal Surgery

Interventions

DEVICE

CG-100 Intraluminal Bypass Device

Intended to reduce contact of fecal content with an anastomotic site , following colorectal surgery.

Sponsors & Collaborators

  • Colospan Ltd.

    lead INDUSTRY

Principal Investigators

  • Ilia Pinsk, MD · Soroka University Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-06-01
Completion
2019-07-31

Countries

  • France
  • Germany
  • Israel
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03423485 on ClinicalTrials.gov